Task: Answer the multiple-choice question.
Question: Which compound exhibits a 17.613% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: O=C(O)c1cc2[nH]c3c(c2cc1Cl)CCCC3
b: Cc1cc(=O)nc2c3ccccc3n(CC(=O)NCCCN3CCOCC3)n12
Answer: b. Cc1cc(=O)nc2c3ccccc3n(CC(=O)NCCCN3CCOCC3)n12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(=O)nc2c3ccccc3n(CC(=O)NCCCN3CCOCC3)n12
Cc1cc(=O)nc2c3ccccc3n(CC(=O)NCCCN3CCOCC3)n12
2-(4-methyl-2-oxopyrimido[1,2-b]indazol-6-yl)-N-(3-morpholin-4-ylpropyl)acetamide